ahlam1399
07-24-2015, 04:57 PM
**vartis mela**ma drug combination wins EU green light
LONDON (Reuters) - European regulators on Friday recommended the use of a combination of **vartis's ***** Tafinlar and Mekinist for treating certain patients with mela**ma, boosting prospects for medicines acquired from GlaxoSmithKline.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/486761cb/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=RPQvGb966vA:EZtJGa9xXIM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=RPQvGb966vA:EZtJGa9xXIM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=RPQvGb966vA:EZtJGa9xXIM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=RPQvGb966vA:EZtJGa9xXIM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=RPQvGb966vA:EZtJGa9xXIM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/RPQvGb966vA
LONDON (Reuters) - European regulators on Friday recommended the use of a combination of **vartis's ***** Tafinlar and Mekinist for treating certain patients with mela**ma, boosting prospects for medicines acquired from GlaxoSmithKline.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/486761cb/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=RPQvGb966vA:EZtJGa9xXIM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=RPQvGb966vA:EZtJGa9xXIM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=RPQvGb966vA:EZtJGa9xXIM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=RPQvGb966vA:EZtJGa9xXIM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=RPQvGb966vA:EZtJGa9xXIM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/RPQvGb966vA